AstraZeneca Crestor Pricing On Par With Lipitor; Pattern Could Repeat In U.S.
AstraZeneca is unlikely to seek a premium price for Crestor when it is launched in the U.S., CEO Tom McKillop indicated on a July 24 earnings call
AstraZeneca is unlikely to seek a premium price for Crestor when it is launched in the U.S., CEO Tom McKillop indicated on a July 24 earnings call